Commentary
DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis
-
* Corresponding author: Piet LCM van Riel p.vanriel@reuma.umcn.nl
Arthritis Research & Therapy 2005, 7:189-190 doi:10.1186/ar1820
No comments have yet been made on this article.